Skip to content

Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation

Effectiveness of an Advanced Practice Nurse-led Self-management Program on Prevention of Weight Gain, Physical Activity and Medication Adherence in Patients in the First Year After Renal Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02282124
Acronym
SMP-NEP
Enrollment
122
Registered
2014-11-04
Start date
2012-05-31
Completion date
2018-02-28
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation, Rental Transplantation

Keywords

weight, self-management, exercise

Brief summary

The aim of this study is to investigate the effectiveness of the program in patients after renal transplantation using a randomized controlled trial design. Physical, behavioural, and clinical outcomes will be measured at baseline before randomization then 8 and 12 months later.

Detailed description

Renal transplant recipients have to integrate preventive behaviours into their everyday lives. From the literature it is known that patients can only partially adhere to the recommended behaviours. An evidence-based self-management program to support patients in behaviour change was developed with a main focus on prevention of weight gain and increasing physical activity and medication adherence. The aim of this study is to investigate the effectiveness of the program in patients in the first year after renal transplantation. The specific aims of this study are: 1. Compare differences in weight gain between subjects in the IG (intervention group) and in the CG (control group). 2. Compare differences in the amount of physical exercise between subjects in the IG group and the CG. 3. Compare differences in self-reported medication adherence between the subjects of the IG group and the CG. Secondarily, differences in self-reported quality of life, anxiety and depression, and differences in patients' perception of health care provision regarding chronic illness between the subjects of the IG group and the CG will be compared. Design: Randomised controlled trial, not blinded Setting and time: The study will take place at the Nephrology Clinic, University Hospital Zürich, from 1 May 2012 through 31 April 2015. Variables and Measurement: Physical, behavioural, and clinical outcomes will be measured at baseline, before randomization and then 8 and 12 months later. Medication adherence, physical activity, symptoms of depression and anxiety, quality of life and patients' perception of health care provided will be measured with validated questionnaires. Body weight, height, waist to hip ratio and body composition (BCM Fresenius) will be measured at the Nephrology Clinic. Physical activity will be measured with the pedometer StepWatchTM. Intervention

Interventions

BEHAVIORALSelf-management program with monthly sessions

Patients participate in 9 sessions during the first 8th month after transplantaiton

BEHAVIORALUsual Care, containing one session

Session takes place within the first three months after transplantation

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* received a kidney or a kidney-pancreas transplant in the University Hospital Zürich

Exclusion criteria

* unstable psychiatric disorder * cognitive impairment * multi-organ transplantation with lung * liver or heart * illiteracy * not able to speak and understand German

Design outcomes

Primary

MeasureTime frameDescription
change from baseline BMI at 8 months8th monthBMI

Secondary

MeasureTime frameDescription
difference of activity between control and intervention group at month 12month 12differences in steps measured with pedometer (Stepwatch)
change from baseline BMI at 12 months12th monthBMI
difference of self-reported adherence between control and intervention group at month 8month 8
difference of activity between control and intervention group at month 8month 8differences in steps measured with pedometer (Stepwatch)
change from baseline LTM at 8 months8 monthsLTM measured with Body Composition Analysis
change from baseline LTM at 12 months12 monthsLTM measured with Body Composition Analysis
difference of self-reported adherence between control and intervention group at month 12month 12

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026